Research Output per year
Fingerprint Dive into the research topics where Loredana Amoroso is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 7 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer
Moreno, L., Casanova, M., Chisholm, J. C., Berlanga, P., Chastagner, P. B., Baruchel, S., Amoroso, L., Gallego Melcón, S., Gerber, N. U., Bisogno, G., Fagioli, F., Geoerger, B., Glade Bender, J. L., Aerts, I., Bergeron, C., Hingorani, P., Elias, I., Simcock, M., Ferrara, S., Le Bruchec, Y. & 3 others, , Sep 2018, In : European Journal of Cancer. 100, p. 27-34 8 p.Research output: Contribution to journal › Article
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer
Moreno, L., Casanova, M., Chisholm, J. C., Berlanga, P., Chastagner, P. B., Baruchel, S., Amoroso, L., Melcón, S. G., Gerber, N. U., Bisogno, G., Fagioli, F., Geoerger, B., Glade Bender, J. L., Aerts, I., Bergeron, C., Hingorani, P., Elias, I., Simcock, M., Ferrara, S., Le Bruchec, Y. & 3 others, , 2018, In : European journal of cancer. 100, p. 27-34 8 p.Research output: Contribution to journal › Article
Topotecan-vincristine-doxorubicin in stage 4 high-risk neuroblastoma patients failing to achieve a complete metastatic response to rapid COJEC: A SIOPEN study
Amoroso, L., Erminio, G., Makin, G., Pearson, A. D. J., Brock, P., Valteau-Couanet, D., Castel, V., Pasquet, M., Laureys, G., Thomas, C., Luksch, R., Ladenstein, R., Haupt, R., Garaventa, A. & On behalf of SIOPEN Group, Jan 1 2018, In : Cancer Research and Treatment. 50, 1, p. 148-155 8 p.Research output: Contribution to journal › Article
Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study
SIOPEN Group, Jan 2018, In : Cancer Research and Treatment. 50, 1, p. 148-155 8 p.Research output: Contribution to journal › Article
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma
Morandi, F., Amoroso, L., Dondero, A., Castriconi, R., Parodi, S., Luksch, R., Casale, F., Castellano, A., Garaventa, A., Moretta, A., Bottino, C., Ponzoni, M. & Corrias, M. V., 2018, In : OncoImmunology. 7, 9, p. e1468953Research output: Contribution to journal › Article